Literature DB >> 15763581

The taste of sickness: lipopolysaccharide-induced finickiness in rats.

Arnaud Aubert1, Robert Dantzer.   

Abstract

Decrease in food intake is one of the most documented non-specific symptoms of inflammatory processes. However, attention has been mainly focused on quantitative analysis. The present paper reports studies undertaken to test the possible contribution of changes in taste processes in inflammatory-induced alteration of feeding behavior. In a first experiment, the effects of lipopolysaccharide-induced sickness were assessed on preference for saccharin and aversion for quinine in rats using the two-bottle test paradigm. In a second experiment, effect of lipopolysaccharide (LPS) on the behavioral reactivity to palatable, unpalatable and mixed solutions was analyzed using the taste-reactivity paradigm. Our results show that LPS decreased total fluid intake but did not change taste responses to unpalatable or palatable substances. However, LPS increased aversive reactions and decreased hedonic responses to mixed taste. These LPS-induced changes are interpreted as an increase in finickiness and are discussed in regard to their potential role in the adaptation of individuals to sickness.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15763581     DOI: 10.1016/j.physbeh.2005.01.006

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  12 in total

1.  Inflammation-induced motivational changes: Perspective gained by evaluating positive and negative valence systems.

Authors:  Elisabeth G Vichaya; Robert Dantzer
Journal:  Curr Opin Behav Sci       Date:  2018-02-10

2.  How does immune challenge inhibit ingestion of palatable food? Evidence that systemic lipopolysaccharide treatment modulates key nodal points of feeding neurocircuitry.

Authors:  Su-Mi Park; Ron P A Gaykema; Lisa E Goehler
Journal:  Brain Behav Immun       Date:  2008-06-17       Impact factor: 7.217

Review 3.  Participation of α2 -adrenoceptors in sodium appetite inhibition during sickness behaviour following administration of lipopolysaccharide.

Authors:  Laurival A De Luca; Roberto L Almeida; Richard B David; Patricia M de Paula; Carina A F Andrade; José V Menani
Journal:  J Physiol       Date:  2015-07-07       Impact factor: 5.182

4.  Symptom cluster analyses based on symptom occurrence and severity ratings among pediatric oncology patients during myelosuppressive chemotherapy.

Authors:  Christina Baggott; Bruce A Cooper; Neyssa Marina; Katherine K Matthay; Christine Miaskowski
Journal:  Cancer Nurs       Date:  2012 Jan-Feb       Impact factor: 2.592

5.  Lipopolysaccharide Alters Motivated Behavior in a Monetary Reward Task: a Randomized Trial.

Authors:  Julie Lasselin; Michael T Treadway; Tamara E Lacourt; Anne Soop; Mats J Olsson; Bianka Karshikoff; Sofie Paues-Göranson; John Axelsson; Robert Dantzer; Mats Lekander
Journal:  Neuropsychopharmacology       Date:  2016-09-13       Impact factor: 7.853

6.  Lipopolysaccharide-induced inflammation attenuates taste progenitor cell proliferation and shortens the life span of taste bud cells.

Authors:  Zachary J Cohn; Agnes Kim; Liquan Huang; Joseph Brand; Hong Wang
Journal:  BMC Neurosci       Date:  2010-06-10       Impact factor: 3.288

7.  Neurobiology of inflammation-associated anorexia.

Authors:  Laurent Gautron; Sophie Layé
Journal:  Front Neurosci       Date:  2010-01-08       Impact factor: 4.677

8.  Inflammation activates the interferon signaling pathways in taste bud cells.

Authors:  Hong Wang; Minliang Zhou; Joseph Brand; Liquan Huang
Journal:  J Neurosci       Date:  2007-10-03       Impact factor: 6.167

9.  Lipopolysaccharide reduces incentive motivation while boosting preference for high reward in mice.

Authors:  Elisabeth G Vichaya; Sarah C Hunt; Robert Dantzer
Journal:  Neuropsychopharmacology       Date:  2014-06-11       Impact factor: 7.853

10.  Lipopolysaccharide does not alter behavioral response to successive negative contrast in mice.

Authors:  Angela M Casaril; Elisabeth G Vichaya; M Raafay Rishi; Bianca G Ford; Robert Dantzer
Journal:  Psychopharmacology (Berl)       Date:  2021-01-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.